Patents by Inventor John Joseph Feeney

John Joseph Feeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of circadian rhythm disorders
    Patent number: 11918556
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: March 5, 2024
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20240016791
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Application
    Filed: September 26, 2023
    Publication date: January 18, 2024
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • Treatment of circadian rhythm disorders
    Patent number: 11850229
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: December 26, 2023
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 11833130
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: December 5, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 11826339
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: November 28, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20220175716
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 9, 2022
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20220168263
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20220168264
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 11285129
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: March 29, 2022
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20210330634
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: July 6, 2021
    Publication date: October 28, 2021
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 11090285
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: August 17, 2021
    Assignee: VANDA PHARMACEUTICALS INC
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20210205261
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20210128517
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 6, 2021
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 10980770
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: February 16, 2020
    Date of Patent: April 20, 2021
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20210015809
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 21, 2021
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • Iloperidone metabolite for use in the treatment of psychiatric disorders
    Patent number: 10874659
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 29, 2020
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20200179326
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: February 16, 2020
    Publication date: June 11, 2020
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 10610510
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: April 7, 2020
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20190133991
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 9, 2019
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20190070144
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: November 5, 2018
    Publication date: March 7, 2019
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos